- Home
- ACIU vs DXYZ Comparison
ACIU vs DXYZ Comparison
Compare ACIU & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- DXYZ
- Stock Information
- Founded
- ACIU 2003
- DXYZ N/A
- Country
- ACIU Switzerland
- DXYZ
- Employees
- ACIU N/A
- DXYZ N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- DXYZ
- Sector
- ACIU Health Care
- DXYZ
- Exchange
- ACIU Nasdaq
- DXYZ Nasdaq
- Market Cap
- ACIU 332.4M
- DXYZ 350.2M
- IPO Year
- ACIU 2016
- DXYZ 2024
- Fundamental
- Price
- ACIU $2.68
- DXYZ $60.09
- Analyst Decision
- ACIU Strong Buy
- DXYZ
- Analyst Count
- ACIU 2
- DXYZ 0
- Target Price
- ACIU $12.00
- DXYZ N/A
- AVG Volume (30 Days)
- ACIU 134.5K
- DXYZ N/A
- Earning Date
- ACIU 11-05-2024
- DXYZ N/A
- Dividend Yield
- ACIU N/A
- DXYZ N/A
- EPS Growth
- ACIU N/A
- DXYZ N/A
- EPS
- ACIU N/A
- DXYZ N/A
- Revenue
- ACIU $48,505,404.00
- DXYZ N/A
- Revenue This Year
- ACIU $85.33
- DXYZ N/A
- Revenue Next Year
- ACIU $80.69
- DXYZ N/A
- P/E Ratio
- ACIU N/A
- DXYZ N/A
- Revenue Growth
- ACIU 4097200.00
- DXYZ N/A
- 52 Week Low
- ACIU $2.25
- DXYZ N/A
- 52 Week High
- ACIU $5.14
- DXYZ N/A
- Technical
- Relative Strength Index (RSI)
- ACIU 27.49
- DXYZ N/A
- Support Level
- ACIU $2.62
- DXYZ N/A
- Resistance Level
- ACIU $3.02
- DXYZ N/A
- Average True Range (ATR)
- ACIU 0.13
- DXYZ 0.00
- MACD
- ACIU -0.05
- DXYZ 0.00
- Stochastic Oscillator
- ACIU 9.52
- DXYZ 0.00
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About DXYZ Destiny Tech100 Inc. Common Stock
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.